EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center

Akira Kawai iD, Akihiko Yoshida, Tatsunori Shimoi, Eisuke Kobayashi iD, Kan Yonemori, Koichi Ogura iD, Shintaro Iwata iD, Nishida Toshirou

Cancer Science · 2024

DOI: 10.1111/cas.16211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Akira Kawai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Soft Tissue Neoplasms, Sarcoma, Bone Neoplasms, Referral and Consultation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MHLW Research for Promotion of Cancer Control Programmes, National Cancer Center Research and Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histological diagnosis of sarcomas (malignant bone and soft tissue tumors) is challenging due to their rarity, morphological diversity, and constantly evolving diagnostic criteria. In this study, we aimed to assess the concordance in histological diagnosis of bone and soft tissue tumors between referring hospitals and a tertiary sarcoma center and analyzed the clinical impact of the diagnostic alteration. We analyzed 628 consecutively accessioned specimens from 624 patients who visited a specialized sarcoma center for treatment. The diagnoses at referring hospitals and those at the sarcoma center were compared and classified into four categories: agreed, disagreed, specified, and de‐specified. Of the 628 specimens, the diagnoses agreed in 403 (64.2%) specimens, whereas some changes were made in 225 (35.8%) specimens: disagreed in 153 (24.3%), specified in 52 (8.3%), and de‐specified in 20 (3.2%) cases. The benign/intermediate/malignant judgment changed for 92 cases (14.6%). The diagnostic change resulted in patient management modification in 91 cases (14.5%), including surgical and medical treatment changes. The main inferred reason for the diagnostic discrepancies was a different interpretation of morphological findings of the tumor, which accounted for 48.9% of the cases. This was followed by the unavailability of specialized immunohistochemical antibodies and the unavailability of genetic analysis. In summary, our study clarified the actual clinical impact of diagnostic discrepancy in bone and soft tissue tumors. This may underscore the value of pathology consultation, facilitating access to specialized diagnostic tools, and continued education. These measures are expected to improve diagnostic precision and ultimately benefit patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soft Tissue NeoplasmsSarcomaBone NeoplasmsReferral and ConsultationHumansMaleFemaleMiddle AgedAdultAgedAdolescentYoung AdultChildAged, 80 and overDiagnostic ErrorsTertiary Care CentersChild, Preschool

Stichwörter der Autor:innen

bone and soft tissue tumorsconcordancehistological diagnosisrare cancerstreatment changes

Autor:innen und Institutionen

  • Department of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, Tokyo, Japan.
  • Rare Cancer Center, National Cancer Center, Tokyo, Japan.
  • Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.

ORCID-Profile: Akira Kawai, Eisuke Kobayashi, Koichi Ogura, Shintaro Iwata

Förderung

  • MHLW Research for Promotion of Cancer Control Programmes
  • National Cancer Center Research and Development Funds

Zitieren

APA

Kawai, A., Yoshida, A., Shimoi, T., Kobayashi, E., Yonemori, K., Ogura, K., Iwata, S., & Toshirou, N. (2024). Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center. Cancer Science. https://doi.org/10.1111/cas.16211

Vancouver

Kawai A, Yoshida A, Shimoi T, Kobayashi E, Yonemori K, Ogura K, et al. Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center. Cancer Science. 2024. doi:10.1111/cas.16211

BibTeX
@article{Kawai2024,
  author = {Kawai, Akira and Yoshida, Akihiko and Shimoi, Tatsunori and Kobayashi, Eisuke and Yonemori, Kan and Ogura, Koichi and Iwata, Shintaro and Toshirou, Nishida},
  title = {Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16211}
}
Kostenlos starten →